Mycotoxines : facteur de risque de cancers

[1]  R. Manderville,et al.  Formation of 2'-deoxyguanosine-carbon 8-bound ochratoxin A adduct in rat kidney DNA. , 2009, Molecular nutrition & food research.

[2]  R. Manderville,et al.  Combined Toxic Effects of Ochratoxin A and Citrinin, In Vivo and In Vitro , 2008 .

[3]  W. Marasas,et al.  Cancer initiating properties of fumonisin B1 in a short-term rat liver carcinogenesis assay. , 2008, Toxicology.

[4]  R. Manderville,et al.  Bioactivation and DNA adduction as a rationale for ochratoxin A carcinogenesis , 2008 .

[5]  J. Wagacha,et al.  Mycotoxin problem in Africa: current status, implications to food safety and health and possible management strategies. , 2008, International journal of food microbiology.

[6]  C. Wild,et al.  Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries. , 2008, Annual Review of Public Health.

[7]  C. Wild,et al.  Association between Tortilla Consumption and Human Urinary Fumonisin B1 Levels in a Mexican Population , 2008, Cancer Epidemiology Biomarkers & Prevention.

[8]  A. Pfohl‐Leszkowicz,et al.  Chapter 7 Formation, Persistence and Significance of DNA Adduct Formation in Relation to Some Pollutants from a Broad Perspective , 2008 .

[9]  L. Tang,et al.  Validation of fumonisin biomarkers in F344 rats. , 2007, Toxicology and applied pharmacology.

[10]  A. Brown,et al.  DNA ploidy distribution in renal tumours induced in male rats by dietary ochratoxin A. , 2007, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[11]  R. Manderville,et al.  New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor. , 2007, Molecular nutrition & food research.

[12]  Samuel H. Wilson,et al.  Ochratoxin A-induced mutagenesis in mammalian cells is consistent with the production of oxidative stress. , 2007, Chemical research in toxicology.

[13]  P. W. Snijman,et al.  Altered Lipid Parameters in Hepatic Subcellular Membrane Fractions Induced by Fumonisin B1 , 2007, Lipids.

[14]  A. Sammon.  Carcinogens and endemic squamous cancer of the oesophagus in Transkei, South Africa. Environmental initiation is the dominant factor; tobacco or other carcinogens of low potency or concentration are sufficient for carcinogenesis in the predisposed mucosa. , 2007, Medical hypotheses.

[15]  R. Manderville,et al.  Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans. , 2007, Molecular nutrition & food research.

[16]  H. Ahsan,et al.  Aflatoxin B1 and polycyclic aromatic hydrocarbon adducts, p53 mutations and p16 methylation in liver tissue and plasma of hepatocellular carcinoma patients , 2006, International journal of cancer.

[17]  R. Manderville,et al.  Genotoxicity of the hydroquinone metabolite of ochratoxin A: structure-activity relationships for covalent DNA adduction. , 2006, Chemical research in toxicology.

[18]  F. Pont,et al.  Evidence of a new dechlorinated ochratoxin A derivative formed in opossum kidney cell cultures after pretreatment by modulators of glutathione pathways: correlation with DNA-adduct formation. , 2006, Molecular nutrition & food research.

[19]  Jia-Sheng Wang,et al.  Efficient activation of aflatoxin B1 by cytochrome P450 2A13, an enzyme predominantly expressed in human respiratory tract , 2006, International journal of cancer.

[20]  T. Vrabcheva,et al.  Balkan endemic nephropathy: role of ochratoxins A through biomarkers. , 2006, Molecular nutrition & food research.

[21]  J. Corton,et al.  The role of tumor necrosis factor α and the peroxisome proliferator-activated receptor α in modulating the effects of fumonisin in mouse liver , 2006 .

[22]  D. Toncheva,et al.  Etiology of Balkan Endemic Nephropathy and Associated Urothelial Cancer , 2006, American Journal of Nephrology.

[23]  M. Castegnaro,et al.  Analysis of some breakfast cereals on the French market for their contents of ochratoxin A, citrinin and fumonisin B1: development of a method for simultaneous extraction of ochratoxin A and citrinin , 2005 .

[24]  K. Lindblade,et al.  Case–Control Study of an Acute Aflatoxicosis Outbreak, Kenya, 2004 , 2005, Environmental health perspectives.

[25]  M. Castegnaro,et al.  Further arguments in favour of direct covalent binding of Ochratoxin A (OTA) after metabolic biotransformation , 2005, Food additives and contaminants.

[26]  E. Kulinskaya,et al.  Renal tumourigenesis in male rats in response to chronic dietary ochratoxin A , 2005, Food additives and contaminants.

[27]  R. Manderville,et al.  Evidence for covalent DNA adduction by ochratoxin A following chronic exposure to rat and subacute exposure to pig. , 2004, Chemical research in toxicology.

[28]  W. Marasas,et al.  Fumonisin B1-induced hepatocellular and cholangiocellular tumors in male Fischer 344 rats: potentiating effects of 2-acetylaminofluorene on oval cell proliferation and neoplastic development in a discontinued feeding study. , 2004, Carcinogenesis.

[29]  A. Hall,et al.  Postweaning Exposure to Aflatoxin Results in Impaired Child Growth: A Longitudinal Study in Benin, West Africa , 2004, Environmental health perspectives.

[30]  A J Hall,et al.  Determinants of aflatoxin exposure in young children from Benin and Togo, West Africa: the critical role of weaning. , 2003, International journal of epidemiology.

[31]  K. Kang,et al.  Strain‐specific mammary proliferative lesion development following lifetime oral administration of ochratoxin A in DA and Lewis rats , 2003, International journal of cancer.

[32]  Leslie T. Stayner,et al.  IARC Monographs on the evaluation of carcinogenic risks to humans: Some traditional herbal medicines, some mycotoxins, naphthalene and styrene , 2002 .

[33]  W. Marasas,et al.  Interaction of fumonisin B(1) and aflatoxin B(1) in a short-term carcinogenesis model in rat liver. , 2002, Toxicology.

[34]  H. Bartsch,et al.  MESNA PROTECTS RATS AGAINST NEPHROTOXICITY BUT NOT CARCINOGENICITY INDUCED BY OCHRATOXIN A, IMPLICATING TWO SEPARATE PATHWAYS , 2002 .

[35]  H. Bartsch,et al.  Sex‐ and strain‐specific expression of cytochrome P450s in Ochratoxin A‐induced genotoxicity and carcinogenicity in rats , 1998, Molecular carcinogenesis.

[36]  H. Bartsch,et al.  Sex‐ and strain‐specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction , 1998 .

[37]  P. Mantle,et al.  Porcine nephropathy in Bulgaria: a progressive syndrome of complex or uncertain (mycotoxin) aetiology , 1998, Veterinary Record.

[38]  M. Clapper,et al.  Glutathione S-transferase expression in hepatitis B virus-associated human hepatocellular carcinogenesis. , 1997, Cancer research.

[39]  M. Katsuki,et al.  In vivo activation of aflatoxin B1 in C57BL/6N mice carrying a human fetus-specific CYP3A7 gene. , 1997, Cancer research.

[40]  G. Batist,et al.  Overexpression of Cytochrome P-450 Isoforms Involved in Aflatoxin B1 Bioactivation in Human Liver with Cirrhosis and Hepatitis , 1996, Toxicologic pathology.

[41]  T. Massey,et al.  Bioactivation of aflatoxin B1 by lipoxygenases, prostaglandin H synthase and cytochrome P450 monooxygenase in guinea-pig tissues. , 1992, Carcinogenesis.